EMA Panel Backs Approval of Revolution Medicines' Pancreatic Cancer Drug

AI-generated NewsSnap summary based on source reporting.
Published: 2026-10-15T23:16:11Z
Category: health
Source: Ground News (citing Reuters)

A European Medicines Agency (EMA) committee has recommended approval for Revolution Medicines' Rasonque, a drug for adults with pancreatic cancer that has spread and worsened after at least one prior treatment. This recommendation could lead to the drug's availability in the EU.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai